Evidence map›Paper›PMID 37167575›Full record

ArticleJCO global oncology2023

Fragmentation of Care and Its Association With Survival and Costs for Patients With Breast Cancer in Colombia.

Óscar Gamboa, Giancarlo Buitrago, Andrés Felipe Patiño, Nicolás Rozo Agudelo, Laura Saldaña Espinel, Javier Eslava-Schmalbach, Óscar Guevara, Rubén Caycedo, Edgar Junca, Carlos Bonilla and 1 more

Open access · goldAbstract read
In one paragraph

Article in JCO global oncology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
12.0field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 21 citations in OpenAlex.

  1. Pooled it
  2. Clinical and prognostic factors in pleural mesothelioma: insights from a Latin American cohort.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Observational
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Óscar GamboaInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0002-9329-6810
Giancarlo BuitragoInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0002-7466-8244
Andrés Felipe PatiñoInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0002-0501-3287
Nicolás Rozo AgudeloInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0003-0409-2515
Laura Saldaña EspinelInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Javier Eslava-SchmalbachInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0003-1502-2918
Óscar GuevaraInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0001-9099-8131
Rubén CaycedoInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Edgar JuncaInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.
Carlos BonillaFundación CTIC, Centro de Tratamiento e Investigación sobre Cáncer, Bogotá D.C., Colombia.ORCID 0000-0002-6323-9612
Ricardo SánchezInstituto de Investigaciones Clínicas, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá D.C., Colombia.ORCID 0000-0002-7540-4734
Universidad Nacional de Colombia · CO

Funding

Department of Health NIHR150067
6 · The paper itself

Abstract

purposeBreast cancer care requires a multimodal approach and a multidisciplinary team who must work together to obtain good clinical results. The fragmentation of care can affect the breast cancer care; however, it has not been measured in a low-resource setting. The aim of this study was to identify fragmentation of care, the geographic variation of this and its association with 4-year overall survival (OS), and costs of care for patients with breast cancer enrolled in Colombia's contributory health care system. MATERIALS AND

methodsA retrospective cohort study was conducted using administrative databases. Women with breast cancer who were treated from January 1, 2013, to December 31, 2015, were included. Fragmentation of care was the exposure, which was measured by the number of different health care provider institutions (HCPIs) that treated a patient during the first year after diagnosis. Crude mortality rates were estimated, survival functions were calculated using the nonparametric Kaplan-Meier approach, and adjusted hazard ratios (HRs) were estimated using multivariate Cox regression model to identify the association of fragmentation with 4-year OS. The association between fragmentation and costs of care was assessed using a multivariate linear regression model.

resultsA total of 10,999 patients with breast cancer were identified, and 1,332 deaths were observed. The 4-year crude mortality rate was 31.97 (95% CI, 30.25 to 33.69) per 1,000 person-years for the whole cohort, and the highest rate was in the cohort defined for the fourth quartile of the fragmentation measurement (eight or more HCPIs), 40.94 (95% CI, 36.49 to 45.39). The adjusted HR for 4-year OS was 1.04 (95% CI, 1.01 to 1.07) for each HCPI additional. The cost of care is increased for each additional HCPIs (cost ratio, 1.25; 95% CI, 1.23 to 1.26).

conclusionFragmentation of care decreases overall 4-year OS and increases the costs of care in women with breast cancer for Colombia.

Indexed as

Breast NeoplasmsColombiaFemaleHumansRetrospective Studies

Identifiers

PMID37167575
PMCPMC10497266
OpenAlexW4376225085

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.